Home/Filings/4/0001600132-17-000034
4//SEC Filing

Bellerophon Therapeutics, Inc. 4

Accession 0001600132-17-000034

CIK 0001600132operating

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 4:32 PM ET

Size

4.5 KB

Accession

0001600132-17-000034

Insider Transaction Report

Form 4
Period: 2017-03-16
Schoeps Megan
Principal Financial Officer
Transactions
  • Award

    Common Stock

    2017-03-16+24,03928,707 total

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001600132

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:32 PM ET
Size
4.5 KB